MRC Global (MRC) Q4 2024 earnings summary

Executive summary

• Full-year 2024 revenue was $3.011 billion, down 8% from 2023, with net income from continuing operations of $78 million and adjusted EBITDA of $202 million (6.7% of sales).

• Q4 2024 sales were $664 million, with a net loss from continuing operations of $1 million and adjusted EBITDA of $32 million (4.8% of sales).

• Operating cash flow from continuing operations reached $268 million, a record high since 2015, driven by improved working capital efficiency.

• Strategic actions included simplification of capital structure, sale of the Canada business (expected to close March 2025), and initiation of a $125 million share buyback program.

• Growth initiatives in chemicals, mining, data centers, and the IMTEC JV are expected to drive 2025 revenue.

Financial highlights

• Adjusted gross profit margin for 2024 was 21.9%, with Q4 at 22.0%; full-year margin exceeded 21% for the third consecutive year.

• Adjusted EBITDA for 2024 was $202 million (6.7% of sales); Q4 adjusted EBITDA was $32 million.

• Net loss from continuing operations in Q4 was $1 million; adjusted net income for 2024 was $86 million.

• Net working capital to sales ratio reached a record low of 11.2% in Q4.

• Year-end liquidity was $523 million, including $460 million ABL availability and $63 million cash.

Outlook and guidance

• 2025 revenue is projected to grow low to high single digits year-over-year, with all business sectors contributing.

• Adjusted gross margin is expected to average ~21%; adjusted SG&A to be 15%-16% of revenue.

• Operating cash flow guidance is at least $100 million; CapEx expected at $45 million due to ERP implementation.

• Sequential revenue growth expected in Q1 and Q2 2025, with Q3 anticipated as the highest quarter.

• Target net debt leverage ratio of 1.5x by year-end 2025.